Reinvent 4 is an AI model developed by AstraZeneca (United Kingdom and Sweden), first published in February 2024. It works in the biology domain, on tasks such as drug discovery.
Epoch AI has no training-compute estimate for this model.
Access: Open weights (unrestricted). Its weights are openly available. The reference paper has 50 citations. Epoch AI rates the confidence of this record as confident.